GlassScriptPhysician profile
Youseung Kim
NPI 1588124606
$868.82
in general payments reported to CMS, 2019-2025
7 companies · $416 in 2025
The $416 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $133 · 2024: $321 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $290.59 | 2025 | Rezdiffra |
| Gilead Sciences, INC. | $244.34 | 2023-2025 | Livdelzi, Vemlidy |
| Janssen Biotech, INC. | $161.53 | 2024 | Stelara, Tremfya, Simponi |
| E.R. Squibb & Sons, L.L.C. | $114.75 | 2024 | Zeposia |
| Phathom Pharmaceuticals, INC. | $30.90 | 2024 | Voquezna |
| Boston Scientific Corporation | $13.38 | 2024 | |
| Intercept Pharmaceuticals, INC. | $13.33 | 2023 | Ocaliva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Youseung Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.